The Role of Anticoagulation in a Patient with Atrial Fibrillation and a CHADS2 Score of 1.
The CHADS2 score is currently the most widely used stroke risk stratification scheme for identifying patients with atrial fibrillation (AF) at low and high risk of stroke, but there is controversy over how to treat those patients whom it identifies as at intermediate risk. This review summarizes current risk scores and discusses additional markers for risk, including echocardiographic parameters, AF subtype, and AF burden, that may provide further insight into thromboembolism risk in patients with indeterminant risk (CHADS2 1).